64Cu-SARTATE not checked

Clarity Pharmaceuticals Ltd · 64Cu-MeCOSar-Octreotate · Cu-64 SARTATE

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“64Cu-SARTATE will be administered at a fixed administration dose, single bolus intravenous injection, peptide mass not exceeding 60µg.”In the company’s words, NCT04438304 on ClinicalTrials.gov
Tested for
Neuroendocrine Tumors, Neuroblastoma, Relapsed Neuroblastoma, Refractory Neuroblastoma
Main trialPhase 2
“The purpose of this study is to assess the performance of imaging agent 64Cu-SARTATE in participants with known or suspected Gastroenteropancreatic (GEP) Neuroendocrine Tumors (NETs) as a potential new way to help diagnose NETs.”In the company’s words, NCT04438304 on ClinicalTrials.gov
Other names
64Cu-MeCOSar-Octreotate · Cu-64 SARTATE · copper 64 SARTATE

Other drugs for Neuroendocrine Tumors

All 245 drugs for Neuroendocrine Tumors

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 2Completed 26 Nov 2024 A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO)
Phase 1/2Terminated 24 Jan 2025 67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow 64Cu-SARTATE

Following is part of Solo: you see every change to 64Cu-SARTATE the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in